Stay updated on IGF-1/IGFBP3 for ROP Prevention Clinical Trial
Sign up to get notified when there's something new on the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page.

Latest updates to the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page
- CheckyesterdayChange DetectedA centralized Locations section was added, listing study sites by state (Alabama, California, Georgia, Mississippi, North Carolina, Oklahoma, West Virginia, Wisconsin). The previously separate per-state location subsections were removed.SummaryDifference0.8%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedPublications section edits clarify that items may be entered voluntarily and may not always relate to the study results, and that some publications are auto-filled from PubMed. The revision tag was updated to v3.3.2.SummaryDifference0.1%

- Check37 days agoChange DetectedThe government funding/status notice banner was removed. This change does not affect the displayed study details or how to navigate the page.SummaryDifference0.3%

- Check51 days agoChange DetectedMinor UI/layout adjustments were observed on the Study Details page, with core content such as eligibility criteria, locations, and outcomes remaining unchanged.SummaryDifference0.3%

- Check80 days agoChange DetectedAdditions introduce a new topic and an updated revision (v3.2.0) along with a government-status notice; the old version (v3.1.0) was removed.SummaryDifference3%

- Check87 days agoChange Detected- Added a new version label (v3.1.0). - Removed the term "Bronchopulmonary dysplasia" from the content.SummaryDifference0.1%

Stay in the know with updates to IGF-1/IGFBP3 for ROP Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page.